Discontinuation report ACCOLATE TAB 20 MG

Last updated on 2018-01-08 History
Report ID 19358
Drug Identification Number 02236606
Brand name ACCOLATE TAB 20 MG
Common or Proper name zafirlukast tablets
Company Name ASTRAZENECA CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ZAFIRLUKAST
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2017-12-31
Actual discontinuation date 2018-01-02
Remaining supply date 2017-12-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-01-08 French Compare
v3 2018-01-08 English Compare
v2 2017-08-15 French Compare
v1 2017-08-15 English Compare

Showing 1 to 4 of 4